Viggo Esmann

2.1k total citations
74 papers, 1.7k citations indexed

About

Viggo Esmann is a scholar working on Molecular Biology, Rheumatology and Organic Chemistry. According to data from OpenAlex, Viggo Esmann has authored 74 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 22 papers in Rheumatology and 14 papers in Organic Chemistry. Recurrent topics in Viggo Esmann's work include Glycosylation and Glycoproteins Research (15 papers), Carbohydrate Chemistry and Synthesis (14 papers) and Glycogen Storage Diseases and Myoclonus (13 papers). Viggo Esmann is often cited by papers focused on Glycosylation and Glycoproteins Research (15 papers), Carbohydrate Chemistry and Synthesis (14 papers) and Glycogen Storage Diseases and Myoclonus (13 papers). Viggo Esmann collaborates with scholars based in Denmark, Spain and United States. Viggo Esmann's co-authors include Henning Juhl, Niels Anker Peterslund, Johannes Ipsen, Henrik Carl Schønheyder, K. Seyer‐Hansen, C. J. Hedeskov, C S Petersen, Carsten Schade Larsen, Troels Herlin and Liselotte Plesner and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Blood.

In The Last Decade

Viggo Esmann

74 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viggo Esmann Denmark 21 542 501 244 221 191 74 1.7k
Edwin A. Peets United States 21 521 1.0× 292 0.6× 73 0.3× 146 0.7× 57 0.3× 32 1.6k
Zenichiro Kato Japan 25 474 0.9× 578 1.2× 218 0.9× 678 3.1× 549 2.9× 111 2.1k
Andrzej Myśliwski Poland 23 500 0.9× 390 0.8× 51 0.2× 927 4.2× 272 1.4× 107 2.1k
G M Vercellotti United States 22 481 0.9× 674 1.3× 99 0.4× 344 1.6× 202 1.1× 33 2.0k
Ralph Zalusky United States 24 223 0.4× 930 1.9× 517 2.1× 245 1.1× 470 2.5× 50 3.2k
B. Rose Canada 23 113 0.2× 299 0.6× 97 0.4× 313 1.4× 309 1.6× 107 1.6k
Steven H. Zuckerman United States 29 344 0.6× 818 1.6× 251 1.0× 1.1k 5.0× 267 1.4× 81 2.7k
Anders Bredberg Sweden 30 474 0.9× 1.3k 2.5× 81 0.3× 699 3.2× 224 1.2× 91 2.9k
Robert L. Hirsch United States 20 583 1.1× 265 0.5× 159 0.7× 736 3.3× 141 0.7× 52 2.1k
Susan Keay United States 33 1.3k 2.3× 648 1.3× 705 2.9× 141 0.6× 106 0.6× 81 3.2k

Countries citing papers authored by Viggo Esmann

Since Specialization
Citations

This map shows the geographic impact of Viggo Esmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viggo Esmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viggo Esmann more than expected).

Fields of papers citing papers by Viggo Esmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viggo Esmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viggo Esmann. The network helps show where Viggo Esmann may publish in the future.

Co-authorship network of co-authors of Viggo Esmann

This figure shows the co-authorship network connecting the top 25 collaborators of Viggo Esmann. A scholar is included among the top collaborators of Viggo Esmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viggo Esmann. Viggo Esmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larsen, Carsten Schade, et al.. (1988). Protein kinase C activity in activated human T-lymphocytes stimulated by interleukin-2. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 969(3). 281–288. 10 indexed citations
2.
Larsen, Carsten Schade, et al.. (1988). Modulation of High‐Affinity Interleukin 2 Receptors on Activated Human T Lymphocytes by Activators of Protein Kinase C. Scandinavian Journal of Immunology. 28(2). 167–175. 5 indexed citations
3.
Larsen, Carsten Schade, et al.. (1988). A study on the role of protein kinase C and intracellular calcium in the activation of superoxide generation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 971(3). 317–324. 14 indexed citations
4.
Rasmussen, Lars Hvilsted, Henning Juhl, Viggo Esmann, & Hans Uffe Petersen. (1988). Glycogen synthase from human and bovine polymorphonuclear leukocyte Immunochemical characterization and comparison to glycogen synthase from rat and rabbit muscle and liver cells. FEBS Letters. 230(1-2). 116–120. 1 indexed citations
5.
Peterslund, Niels Anker, et al.. (1987). Open study of 2-amino-9-(hydroxyethoxymethyl)-9H-purine (desciclovir) in the treatment of herpes zoster. Journal of Antimicrobial Chemotherapy. 20(5). 743–751. 5 indexed citations
6.
Esmann, Viggo, S Kroon, Niels Anker Peterslund, et al.. (1987). PREDNISOLONE DOES NOT PREVENT POST-HERPETIC NEURALGIA. The Lancet. 330(8551). 126–129. 109 indexed citations
7.
Larsen, Carsten Schade, et al.. (1986). Membrane-associated protein kinases in phorbol ester-activated human polymorphonuclear leukocytes. Biochimica et Biophysica Acta (BBA) - General Subjects. 884(1). 54–59. 16 indexed citations
8.
Peterslund, Niels Anker, et al.. (1984). Oral and intravenous acyclovir are equally effective in herpes zoster. Journal of Antimicrobial Chemotherapy. 14(2). 185–189. 32 indexed citations
9.
Peterslund, Niels Anker, K. Seyer‐Hansen, Johannes Ipsen, et al.. (1981). Acvclovir in herpes zoster.. The Lancet. 2. 827–830. 236 indexed citations
10.
Juhl, Henning & Viggo Esmann. (1981). Phosphorylation of glycogen synthase in a homogenate of human polymorphonuclear leukocytes. Molecular and Cellular Biochemistry. 35(2). 93–101. 7 indexed citations
11.
Esmann, Viggo, et al.. (1981). Allosteric and covalent control of glycogen synthase from leukocytes. International Journal of Biochemistry. 13(11). 1123–1126. 5 indexed citations
12.
Thestrup‐Pedersen, Kristian, Viggo Esmann, J Hastrup, et al.. (1980). EPSTEIN-BARR-VIRUS-INDUCED LYMPHOPROLIFERATIVE DISORDER CONVERTING TO FATAL BURKITT-LIKE LYMPHOMA IN A BOY WITH INTERFERON- INDUCIBLE CHROMOSOMAL DEFECT. The Lancet. 316(8202). 997–1002. 38 indexed citations
13.
Esmann, Viggo, et al.. (1975). Inactivation of Glycogen Phosphorylase of Human Polymorphonuclear Leukocytes. Scandinavian Journal of Clinical and Laboratory Investigation. 35(4). 355–361. 4 indexed citations
14.
Ellegaard, J, et al.. (1975). Increased Lymphocyte Atp-Ase Activity In Patients With Carcinomas Of The Oral Cavity And Larynx. Acta Oto-Laryngologica. 80(1-6). 459–464. 2 indexed citations
15.
Esmann, Viggo, et al.. (1973). A Clinical Evaluation of a Rapid Method for Determination of Folate Deficiency by14C-Formate Incorporation into Serine of Lymphocytes. Scandinavian Journal of Clinical and Laboratory Investigation. 31(4). 453–457. 6 indexed citations
16.
Ellegaard, J & Viggo Esmann. (1973). Folate Activity of Human Lymphocytes Determined by Measurement of Serine Synthesis. Scandinavian Journal of Clinical and Laboratory Investigation. 31(1). 9–19. 8 indexed citations
17.
18.
Esmann, Viggo, et al.. (1969). Heredity of leukocyte phosphorylase andamylo-1,6-glucosidase deficiency. The Journal of Pediatrics. 74(1). 90–94. 7 indexed citations
19.
Esmann, Viggo, et al.. (1968). UDP-glucose-glucan glucosyl-transferase activity of polymorphonuclear leukocytes from diabetic subjects. Diabetologia. 4(4). 181–187. 13 indexed citations
20.
Esmann, Viggo. (1963). Effect of Insulin on Human Leucocytes. Diabetes. 12(6). 545–549. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edwin A. Peets Breakdown of academic impact, for papers by Zenichiro Kato Breakdown of academic impact, for papers by Andrzej Myśliwski Breakdown of academic impact, for papers by G M Vercellotti Breakdown of academic impact, for papers by Ralph Zalusky Breakdown of academic impact, for papers by B. Rose Breakdown of academic impact, for papers by Steven H. Zuckerman Breakdown of academic impact, for papers by Anders Bredberg Breakdown of academic impact, for papers by Robert L. Hirsch Breakdown of academic impact, for papers by Susan Keay
Rankless by CCL
2026